US-based biotechnology company Fluxion Biosciences has introduced its new imaging system, the IsoFlux Cytation Imager for automated Circulating tumour cells (CTCs) analysis.

Designed to operate exclusively with the IsoFlux Liquid Biopsy System and CTC Enumeration Kit, the IsoFlux Cytation Imager is pre-configured with the required software and systems for an automated CTC image acquisition.

Fluxion chief technical officer Dr Cristian Ionescu-Zanetti said: “This new imager can scan an entire sample in less than ten minutes, and retains the ability to detect additional protein biomarkers using a fourth fluorescence channel.

"The automated identification of putative CTCs is another big improvement, reducing the total time required per sample by over three times compared to automated microscopes."

“The automated identification of putative CTCs is another big improvement, reducing the total time required per sample by over three times compared to automated microscopes.

“Use of the IsoFlux Cytation Imager will accelerate clinical studies where CTC enumeration, protein marker detection, and cell-based analysis are important readouts.”

The IsoFlux System examines blood to perform a real-time liquid biopsy of the patient’s cancer using the recovered CTCs, which can pave the way for the analysis of DNA, RNA, and proteins.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

CTC detection by protein staining and imaging on an automated microscope has its limitations such as cost and complexity of inverted microscopes.

The new device has been developed to address these limitations by applying all components of a high-end microscope into an easy-to-use plate reader-style package.

The IsoFlux Cytation Imager features an automated stage, autofocus, high-resolution camera, three-colour fluorescence, and the required components for rapid sample scanning and image capture.

It is also fitted with an optional fluorescent channel to detect protein markers, such as AR-V7 for prostate cancer.